D.E. Shaw & Co
OVID icon

D.E. Shaw & Co’s Ovid Therapeutics OVID Stock Holding History

D.E. Shaw & Co’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-71,264
Closed -$217K – 4806
2024
Q1 		$217K Sell
71,264
-7,003
-9% -$23.4K ﹤0.01% 3892
2023
Q4 		$252K Sell
78,267
-6,041
-7% -$20.6K ﹤0.01% 3806
2023
Q3 		$324K Sell
84,308
-22,974
-21% -$82.6K ﹤0.01% 3590
2023
Q2 		$352K Sell
107,282
-231,878
-68% -$787K ﹤0.01% 3549
2023
Q1 		$875K Sell
339,160
-167,167
-33% -$396K ﹤0.01% 3247
2022
Q4 		$942K Sell
506,327
-184,996
-27% -$315K ﹤0.01% 3487
2022
Q3 		$1.27M Sell
691,323
-198,041
-22% -$414K ﹤0.01% 3407
2022
Q2 		$1.91M Buy
889,364
+663
+0.1% +$1.6K ﹤0.01% 3114
2022
Q1 		$2.79M Buy
888,701
+129,605
+17% +$408K ﹤0.01% 2978
2021
Q4 		$2.44M Buy
759,096
+30,166
+4% +$103K ﹤0.01% 3180
2021
Q3 		$2.45M Sell
728,930
-16,985
-2% -$61.9K ﹤0.01% 2844
2021
Q2 		$2.92M Buy
745,915
+160,210
+27% +$632K ﹤0.01% 2557
2021
Q1 		$2.35M Buy
585,705
+373,312
+176% +$1.24M ﹤0.01% 2458
2020
Q4 		$490K Buy
+212,393
New +$990K ﹤0.01% 3400

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return